Raaj Medisafe India Share Price
99.10-2.40 (-2.36%)
+17.15% past 1 Year
Raaj Medisafe India Limited engages in the manufacture trade and sale of medical disposable products in India. Its products comprise syringes needles and perfusion sets.product service is more efficient The
Corporate filings & documents
Announcements
We are glad to inform you that the Company has received a Letter of award from Madhya Pradesh public health services corporation limited for supply of Baby Diappers to various governement hosptials. The Total Value of the order is approximately Rs. 17.02 Crores inclusive of GST.
3 days agoWe are glad to inform you that the Company has received a Letter of award from Madhya Pradesh public health services corporation limited for supply of Baby Diappers to various governement hosptials. The Total Value of the order is approximately Rs. 17.02 Crores inclusive of GST.
3 days agoWe hereby inform that Register of Members Beneficial Owners and Share Transfer Books of the Company will remain Closed from Tuesday September 15 2026 to Monday September 21 2026 (both days inclusive) for the purpose of Annual General Meeting to be held on Monday 21st day of September 2026 at 3.00 pm through VC/OAVM.
5 days agoWe hereby inform that Register of Members Beneficial Owners and Share Transfer Books of the Company will remain Closed from Tuesday September 15 2026 to Monday September 21 2026 (both days inclusive) for the purpose of Annual General Meeting to be held on Monday 21st day of September 2026 at 3.00 pm through VC/OAVM.
5 days agoWe hereby submit the Notice of 41st Annual General meeting of the members of the Company Scheduled to be held on Monday the 21st day of September 2026
1 week agoWe hereby submit the Notice of 41st Annual General meeting of the members of the Company Scheduled to be held on Monday the 21st day of September 2026
1 week agoWe submit herewith letters sent to Shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015 whose e-mail IDs are not registered with Company/RTA/Depositories
1 week agoWe submit herewith letters sent to Shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015 whose e-mail IDs are not registered with Company/RTA/Depositories
1 week agoPursuant to Regulation 34 (1) of SEBI (LODR) Regulations 2015 we submit herewith Annual Report 2026 of the Company.
1 week agoPursuant to Regulation 34 (1) of SEBI (LODR) Regulations 2015 we submit herewith Annual Report 2026 of the Company.
1 week agoWe submit herewith Newspaper cuttings related to publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026 published in Free Press and Chautha Sansar dated 14.08.2026.
2 weeks agoWe submit herewith Newspaper cuttings related to publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026 published in Free Press and Chautha Sansar dated 14.08.2026.
2 weeks agoWe submit herewith Unaudited Financial Results for the Quarter ended June 30 2026 together with Limited Review Report.
3 weeks agoWe submit herewith Unaudited Financial Results for the Quarter ended June 30 2026 together with Limited Review Report.
3 weeks agoWe submit herewith statement of Variation/deviation of utilization of Funds raised by way of Preferential Allotment on 26.03.2026
3 weeks agoWe submit herewith statement of Variation/deviation of utilization of Funds raised by way of Preferential Allotment on 26.03.2026
3 weeks agoThe Board of Directors of the Company in its meeting held on 12.08.2026 has appointed Mr. Vipul Parakh as Chief Financial officer of the Company.
3 weeks agoThe Board of Directors of the Company in its meeting held on 12.08.2026 has appointed Mr. Vipul Parakh as Chief Financial officer of the Company.
3 weeks agoThe Board of Directors in its meeting held on August 121 2026 has inter-alia approved and taken on record Unaudited Financial Results for the quarter ended June 30 2026. Details of other item transacted are as per letter attached.
3 weeks agoThe Board of Directors in its meeting held on August 121 2026 has inter-alia approved and taken on record Unaudited Financial Results for the quarter ended June 30 2026. Details of other item transacted are as per letter attached.
3 weeks agoRaaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday the 12th day of August 2026 at 3.00 PM inter-alia to take on record Unaudited Financial Results of the Company for the Quarter ended June 30 2026. Other items of Business to be transacted as per Agenda attached.
1 month agoRaaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday the 12th day of August 2026 at 3.00 PM inter-alia to take on record Unaudited Financial Results of the Company for the Quarter ended June 30 2026. Other items of Business to be transacted as per Agenda attached.
1 month agoWe forward herewith certificate under regulation 74(5) of SEBI (DP) Regulation 2018 as received from RTA Ankit Consultancy Pvt Ltd.
1 month agoWe forward herewith certificate under regulation 74(5) of SEBI (DP) Regulation 2018 as received from RTA Ankit Consultancy Pvt Ltd.
1 month agoWe forward herewith resignation letter dated July 10 2026 received From Kanije Fatema Dadani Patel resigning from the post of Chief Financial Officer of the Company wef July 14 2026
1 month agoWe forward herewith resignation letter dated July 10 2026 received From Kanije Fatema Dadani Patel resigning from the post of Chief Financial Officer of the Company wef July 14 2026
1 month agoTrading window shall remain closed for trading in shares of the Company for Promoters/Directors/Officers/designated employees and their immediate relatives with effect from July 1 2026 till 48 Hours from the declaration of Unaudited Financial Results for the quarter ending on June 30 2026
2 months agoTrading window shall remain closed for trading in shares of the Company for Promoters/Directors/Officers/designated employees and their immediate relatives with effect from July 1 2026 till 48 Hours from the declaration of Unaudited Financial Results for the quarter ending on June 30 2026
2 months agoWe attach herewith newspaper cuttings related to publication of audited results of the Company for the quarter/year ended March 31 2026 published in Free Press and Chautha Sansar edition dated 31.05.2026.
3 months agoWe attach herewith newspaper cuttings related to publication of audited results of the Company for the quarter/year ended March 31 2026 published in Free Press and Chautha Sansar edition dated 31.05.2026.
3 months agoWe attach herewith Statement of Deviation/Variation under Regulation 32 (1) of SEBI (LODR) Regulations 2015
3 months agoWe attach herewith the following:a. Declaration of unmodified opinionb. Audited Financial Results for he quarter/year ended March 31 2026 Declaration of unmodified opinion Auditors Report Statement of Assets and Liabilities as at that date Cashflow statement for the year ended on that date. Segment reporting for the quarter/year ended on that date.
3 months agoWe attach herewith the following:a. Declaration of unmodified opinionb. Audited Financial Results for he quarter/year ended March 31 2026 Declaration of unmodified opinion Auditors Report Statement of Assets and Liabilities as at that date Cashflow statement for the year ended on that date. Segment reporting for the quarter/year ended on that date.
3 months agoThe Board of Directors of the Company in its meeting held on May 29 2026 has inter-alia approved the following:a. Audited Financial Statements and cash Flow Statements for the year ended March 31 2026.b. Taken a note of the Auditors Report for the year ended March 31 2026.c. Considered and taken on record Audited Financial Results for the quarter and year ended March 31 2026 Cash Flow Statement for the year ended on that that Statement of Assets and Liabilities as at March 31 2026.Other items of Agenda have been approved/taken on record/noted as per letter attached.
3 months agoThe Board of Directors of the Company in its meeting held on May 29 2026 has inter-alia approved the following:a. Audited Financial Statements and cash Flow Statements for the year ended March 31 2026.b. Taken a note of the Auditors Report for the year ended March 31 2026.c. Considered and taken on record Audited Financial Results for the quarter and year ended March 31 2026 Cash Flow Statement for the year ended on that that Statement of Assets and Liabilities as at March 31 2026.Other items of Agenda have been approved/taken on record/noted as per letter attached.
3 months agoWe attach herewith Annual Secretarial Compliance Report for the year ended March 31 2026.
3 months agoWe attach herewith Annual Secretarial Compliance Report for the year ended March 31 2026.
3 months agoRaaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Please be informed that Board Meeting is scheduled to held on Friday the 29th ay of May 2026 at 3.00 PM inter-alia to:1. Consider and approve Financial Statements and Cash Flow Statement for the year ended March 31 2026.2. Consider and to approve Audit Financial Results for the quarter/year ended March 31 2026 Cash Flow Statement and Statement of Assets and Liabilities as at March 31 2026 and to submit the same to Stock Exchange.3. Other items as per Agenda Attached.
3 months agoWe submit herewith a certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
4 months agoWe submit herewith a certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.
4 months agoThe Board of Directors of Raaj Medisafe India Limited (the Company) at its meeting held today i.e. 26th March 2026 approved the allotment of 32 75 000 fully paid-up equity shares having face value of Rs.10/-(Rupees Ten Only) each at a price of Rs.55.00/- (including premium of Rs.45/-) per equity shares. The details attached herewith
5 months agoPlease be informed that Trading Window for trading of equity shares of the Company for Promoter/their immediate relatives/designated persons shall remain closed from April 1 2026 till 48 hours of declaration of Audited Financial Results for the quarter/year ending on March 31 2026.
5 months agoPlease be informed that Trading Window for trading of equity shares of the Company for Promoter/their immediate relatives/designated persons shall remain closed from April 1 2026 till 48 hours of declaration of Audited Financial Results for the quarter/year ending on March 31 2026.
5 months agoRaaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations) we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday March 26 2026 at 3.45 PM at Registered Office of the Company inter alia to transact following businesses: -1. To take note of Minutes of previous Board and committee meetings.2. To issue and allot 32 75 000 equity shares on preferential basis.
5 months agoSubmission of News Paper publication in relation to unaudited financail results for the quarter ended December 31 2025 (Approved in the Board Meeting held on 11th Feb. 2026)
6 months agoSubmission of News Paper publication in relation to unaudited financail results for the quarter ended December 31 2025 (Approved in the Board Meeting held on 11th Feb. 2026)
6 months agoAttached corrigendum to Unadudited Financail Results for the quarter ended December 2025
6 months agoWe are enclosing herewith unaudited financial results along with limited review for the quarter ended on December 31 2025
6 months agoThe Board of Directors of the Company in its meeting held on February 11 2026 has inter-aliaapproved/taken on record as per Board Meeting Notice dated Feb. 02 2026 We are enclosing herewith Outcome of the Board Meeting.
6 months agoRaaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Next Board Meeting is scheduled to be held on 11th February 2026 at 3.00 PM inter-alia to consider and take on records Unaudited Financial Results for the Quarter ended December 31 2025. Other items to be transacted are as per Agenda attached
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
75/2 And 3 Industrial Area Maksi Road Ujjain Madhya Pradesh PIN: 456010 Tel No: 0734-2518989 / 2513349 Fax No: 0734-2526645 Email: [email protected] Internet: www.raajmedisafeindia.com
Registrars
Plot No. 60, Electronic Complex, Pardeshipura, Indore (M.P.)-452010 Plot No 60 Electronic Complex Pardeshipura PIN: Tel No: NULL Fax No: NULL Email: NULL
Management
Arpit Bangur, Chairman & Managing Director
Arpit Bangur, Chairman & Managing Director
Navin Jhawar, Joint Managing Director
Rakesh Agrawal, Non Executive Independent Director
Hemant Kasliwal, Non Executive Independent Director
Ateet Agrawal, Non Executive Independent Director
Sachin Sarda, Company Secretary & Compliance Officer
Krishna Jajoo, Non Executive Director
Details
BSE 524502
NSE NULL
ISIN INE548H01015